Anne Perez

534 total citations
20 papers, 435 citations indexed

About

Anne Perez is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Anne Perez has authored 20 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Anne Perez's work include Cholesterol and Lipid Metabolism (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Anne Perez is often cited by papers focused on Cholesterol and Lipid Metabolism (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Anne Perez collaborates with scholars based in United States, Switzerland and France. Anne Perez's co-authors include Eric J. Niesor, C. Bentzen, Jean‐François Dufour, Olivier Maurhofer, Andrea De Gottardi, Christoph A. Maurer, Mary Betty Stevens, Debra S. Kovacevich, Carol Braunschweig and Jean Flach and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Lipid Research.

In The Last Decade

Anne Perez

17 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Perez United States 11 214 162 121 85 67 20 435
Lily Jakulj Netherlands 11 356 1.7× 114 0.7× 121 1.0× 84 1.0× 86 1.3× 21 462
Fabiana Dalla Vecchia Genvigir Brazil 15 238 1.1× 133 0.8× 129 1.1× 104 1.2× 69 1.0× 29 526
Helen Ambrose United States 8 237 1.1× 223 1.4× 145 1.2× 82 1.0× 65 1.0× 22 618
Catherine E. de Keyser Netherlands 13 93 0.4× 70 0.4× 103 0.9× 79 0.9× 54 0.8× 17 452
Radhakrishnan Rajaratnam Finland 10 430 2.0× 129 0.8× 136 1.1× 91 1.1× 106 1.6× 13 516
Hironobu Mitani Japan 16 206 1.0× 83 0.5× 118 1.0× 44 0.5× 123 1.8× 27 489
T Krechler Czechia 12 107 0.5× 130 0.8× 132 1.1× 81 1.0× 29 0.4× 31 448
E.C.M. de Wit Netherlands 8 364 1.7× 104 0.6× 196 1.6× 100 1.2× 124 1.9× 14 514
Elena Bellafante Italy 9 188 0.9× 208 1.3× 214 1.8× 57 0.7× 63 0.9× 14 608
Marie S. Buchmann Sweden 12 264 1.2× 154 1.0× 179 1.5× 24 0.3× 68 1.0× 24 458

Countries citing papers authored by Anne Perez

Since Specialization
Citations

This map shows the geographic impact of Anne Perez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Perez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Perez more than expected).

Fields of papers citing papers by Anne Perez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Perez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Perez. The network helps show where Anne Perez may publish in the future.

Co-authorship network of co-authors of Anne Perez

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Perez. A scholar is included among the top collaborators of Anne Perez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Perez. Anne Perez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Perez, Anne. (2023). Understanding Zionism. Fortress Press eBooks.
5.
Perez, Anne, et al.. (2023). Educational Initiative to Increase Knowledge for Transition to Adult Care in Adolescents With Cystic Fibrosis. The Journal of Pediatric Pharmacology and Therapeutics. 28(8). 741–746. 3 indexed citations
6.
Perez, Anne, et al.. (2022). Evaluation of Individualized Pain Plans for Children With Sickle Cell Disease Admitted for Vaso-occlusive Crisis at Riley Hospital for Children. The Journal of Pediatric Pharmacology and Therapeutics. 27(4). 312–315. 2 indexed citations
7.
Perez, Anne, et al.. (2022). Dalcetrapib and reduced glutathione effect on hemoglobin S polymerization studied by NMR. Research on Biomedical Engineering. 38(3). 831–838. 3 indexed citations
8.
Niesor, Eric J., Élie Nader, Anne Perez, et al.. (2022). Red Blood Cell Membrane Cholesterol May Be a Key Regulator of Sickle Cell Disease Microvascular Complications. Membranes. 12(11). 1134–1134. 10 indexed citations
9.
Perez, Anne, et al.. (2022). DIMA-fr: a French adaptation and standardization of the Dutch Diagnostic Instrument for Mild Aphasia (DIMA-nl). Clinical Linguistics & Phonetics. 36(11). 954–967. 1 indexed citations
10.
Niesor, Eric J., Guy Boivin, Éric Rhéaume, et al.. (2021). Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib. ACS Omega. 6(25). 16584–16591. 18 indexed citations
11.
Brodeur, Mathieu R., David Rhainds, Evelyne Chaput, et al.. (2017). Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys. Journal of Lipid Research. 58(7). 1282–1291. 12 indexed citations
12.
Niesor, Eric J., Gregory G. Schwartz, Anne Perez, et al.. (2015). Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High-Density Lipoprotein. Cardiovascular Drugs and Therapy. 29(1). 7–14. 53 indexed citations
13.
Maugeais, Cyrille, et al.. (2013). Evidence for a role of CETP in HDL remodeling and cholesterol efflux: Role of cysteine 13 of CETP. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(11). 1644–1650. 22 indexed citations
14.
Perez, Anne, Matthew B. Wright, Cyrille Maugeais, et al.. (2010). MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophages. Toxicology in Vitro. 24(3). 745–750. 11 indexed citations
15.
Clerc, Roger G., Anne Perez, Jean-Christophe Hoflack, et al.. (2010). Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels. Journal of Hypertension. 28(8). 1676–1686. 46 indexed citations
16.
Capponi, Alessandro M., Roger G. Clerc, Luciana Aparecida Campos, et al.. (2008). Abstract 3618: No Increase in the In Vitro Production of Aldosterone or the Expression of CYP11B2 with the CETP Modulator Dalcetrapib (RO4607381/JTT-705), in Contrast with Torcetrapib. Circulation. 118. 6 indexed citations
17.
Gottardi, Andrea De, Christoph A. Maurer, Anne Perez, et al.. (2004). The Bile Acid Nuclear Receptor FXR and the Bile Acid Binding Protein IBABP Are Differently Expressed in Colon Cancer. Digestive Diseases and Sciences. 49(6). 982–989. 120 indexed citations
18.
Roitelman, Joseph, Danièle Masson, Rachel Avner, et al.. (2004). Apomine, a Novel Hypocholesterolemic Agent, Accelerates Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase and Stimulates Low Density Lipoprotein Receptor Activity. Journal of Biological Chemistry. 279(8). 6465–6473. 29 indexed citations
19.
Niesor, Eric J., et al.. (2001). The Nuclear Receptors FXR and LX alpha Potential Targets for the Development of Drugs Affecting Lipid Metabolism and Neoplastic Diseases. Current Pharmaceutical Design. 7(4). 231–259. 45 indexed citations
20.
Kovacevich, Debra S., et al.. (1997). Nutrition Risk Classification: A Reproducible and Valid Tool for Nurses. Nutrition in Clinical Practice. 12(1). 20–25. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026